Meghan Trainor Fires Back at Body-Shamers After Losing 60 Pounds
Meghan Trainor is defending her weight loss. In a new interview, the 31-year-old “Made You Look” singer fired back at body-shamers who have “attacked” her over her 60-pound weight loss and made it clear that she is perfectly healthy. Keep reading to find out more…“I’m literally for the first time ever, after having babies, taking […]
Healthcare, Vol. 13, Pages 2922: Semaglutide in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights
Healthcare, Vol. 13, Pages 2922: Semaglutide in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights Healthcare doi: 10.3390/healthcare13222922 Authors: Faten F. Bin Bin Dayel Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), has demonstrated substantial efficacy in managing type 2 diabetes mellitus (T2DM). It provides glycemic control, promotes weight loss, and offers cardiovascular protection. Evidence […]
1 in 5 U.S. adults say they’ve taken Ozempic or similar drugs, survey finds
Another one in five adults who aren’t using the GLP-1 drugs said they are interested in taking one for weight loss
WeightWatchers to Offer Novo Nordisk’s Wegovy Pill After 2026 Launch
WeightWatchers’ CEO said on Wednesday it planned to offer Novo Nordisk’s much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its… Reuters Health Information
GLP-1s linked to lower colon cancer mortality rates: Study
The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor agonists.
Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
GLP-1 and health: Beyond weight loss in the Ozempic era
This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. The move could significantly expand access to these treatments for people with diabetes and obesity.
Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs – The New York Times
Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs The New York Times Opinion | How to Beat the High Cost of Weight-Loss Drugs The Wall Street Journal Colorado doctors explain benefit after Trump announces plan to lower GLP-1 drug prices CBS News What Trump’s GLP-1 weight-loss drug deal means for Long Island consumers Newsday White House GLP-1 […]
GLP-1 weight-loss medications linked to improved cancer survival…
The trend of unproven peptides is spreading through influencers and RFK Jr. allies
Andrea Steinbrenner receives an IV infusion at Pure Alchemy Wellness, Tuesday, Nov. 11, 2025, in Chula Vista, Calif. (AP Photo/Javier Arciga) 2025-11-14T05:03:15Z WASHINGTON (AP) — More Americans are injecting themselves with unapproved chemicals that are pitched as ways to build muscle, rejuvenate skin and extend life, the latest example of the nation’s fascination with alternative […]